Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 111 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/04/24
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 07/25/19
End: 07/07/22
Due: 07/07/23
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 05/11/17
Due: 05/11/18
Phase: N/A
Priority: Normal
Start: 03/15/13
End: 11/07/17
Due: 11/07/18
Phase: N/A
Priority: Normal
Start: 05/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/21
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 01/10/01
End: 04/27/02
Due: 04/27/03
Phase: N/A
Priority: Normal
Start: 05/09/22
End: 12/21/23
Due: 12/21/24
Phase: N/A
Priority: Normal
Start: 11/13/19
End: 07/20/20
Due: 07/20/21
Phase: N/A
Priority: Normal
Start: 12/13/18
End: 10/13/20
Due: 10/13/21
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/09/19
End: 04/01/22
Due: 04/01/23
Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 11/01/05
End: 03/01/07
Due: 03/01/08
Phase: N/A
Priority: Normal
Start: 04/23/20
End: 09/10/20
Due: 09/10/21
Phase: N/A
Priority: Normal
Start: 06/17/21
End: 02/28/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 08/06/15
End: 11/08/17
Due: 11/08/18
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 10/05/22
End: 05/22/23
Due: 05/22/24
Phase: N/A
Priority: Normal
Start: 12/13/22
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 10/03/22
End: 03/31/29
Due: 03/31/30
Phase: N/A
Priority: Normal
Start: 04/04/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 04/29/22
End: 02/15/23
Due: 02/15/24
Phase: N/A
Priority: Normal
Start: 10/13/00
End: 09/09/02
Due: 09/09/03
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 02/29/16
Due: 02/28/17